Cite
circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop.
MLA
Li, Xiaomin, et al. “CircEXOC6B Interacting with RRAGB, an MTORC1 Activator, Inhibits the Progression of Colorectal Cancer by Antagonizing the HIF1A-RRAGB-MTORC1 Positive Feedback Loop.” Molecular Cancer, vol. 21, no. 1, June 2022, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12943-022-01600-1.
APA
Li, X., Wang, J., Lin, W., Yuan, Q., Lu, Y., Wang, H., Chen, Y., Chen, L., Dai, P., Long, H., & Li, X. (2022). circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Molecular Cancer, 21(1), 1–17. https://doi.org/10.1186/s12943-022-01600-1
Chicago
Li, Xiaomin, Jianjun Wang, Weihao Lin, Qinzi Yuan, Yanxia Lu, Haowei Wang, Yujia Chen, et al. 2022. “CircEXOC6B Interacting with RRAGB, an MTORC1 Activator, Inhibits the Progression of Colorectal Cancer by Antagonizing the HIF1A-RRAGB-MTORC1 Positive Feedback Loop.” Molecular Cancer 21 (1): 1–17. doi:10.1186/s12943-022-01600-1.